IQE PLC

Director's Dealing • Jun 2, 2023

National Storage Mechanism | Additional information

RNS Number : 4216B

IQE PLC

02 June 2023

IQE plc

Cardiff, UK

2 June 2023

Director/PDMR Shareholding

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 1 June 2023 that Dr Drew Nelson, Non-Executive Director, has delivered a further 699,647 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to Equities First Holdings ("EFH"), having received a margin call under the terms of his sale and repurchase agreement with EFH, first announced on 06 August 2019 and extended on 29 July 2022 ("the Agreement"). The total number of Ordinary Shares subject to the sale and repurchase under the Agreement is now 12,821,358 Ordinary Shares ("EFH Sale Shares").

Under the terms of the Agreement, Dr Nelson is obligated to repurchase (and EFH is obligated to sell to Dr Nelson) the EFH Sale Shares at the end of a term ended 5 August 2024. The price at which he has sold and is required to repurchase the EFH Sale Shares remains 43.96 pence per share. All other terms under the Agreement, as disclosed on 6 August 2019, remain unchanged.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1.	Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")
a)	Name	Dr Andrew Nelson
2.	Reason for the notification
a)	Position / status	PDMR (Non-Executive Director)
b)	Initial notification / amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IQE plc
b)	Legal Entity Identifier	213800Y33WHD3ESJJP16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary Shares of 1 pence each in the Company GB0009619924
b)	Nature of the transaction	Delivered a further 699,647 Ordinary Shares to Equities First Holdings under the terms of a sale and repurchase agreement with Equities First Holdings, first announced on 06 August 2019
c)	Price(s) and volume(s)	699,647 Ordinary Shares
d)	Aggregated information ·      Aggregated volume ·      Aggregated price	699,647 Ordinary Shares
e)	Date of the transaction(s)	1 June 2023
f)	Place of the transaction	Outside a trading venue

Contacts:

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

Richard Chambers

James Smith

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

Headland Consultancy (Financial PR)

+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHNKDBNCBKDQAK